Cardiac Output & Its Regulation

Cardiac output (CO) is the volume of blood ejected by one ventricle per minute, given by the fundamental equation: CO (mL/min) = heart rate (beats/min) × stroke volume (mL/beat) For a resting adult, HR ≈ 70 beats/min and SV ≈ 70 mL/beat, giving CO ≈ 4,900 mL/min, conventionally rounded to 5 L/min. Because the pulmonary and systemic circulations are arranged in series, the right and left ventricles must eject the same average output over time, even though they generate very different pressures (right ventricular systolic pressure ≈ 25 mmHg versus left ventricular systolic pressure ≈ 120 mmHg). A related quantity, cardiac index, normalizes CO to body surface area (CO / BSA, normal ≈ 2.6–4.2 L/min/m²), allowing fair comparison across individuals of different size. Stroke volume itself is governed by three physiologically and clinically distinct variables. Preload is the degree of ventricular stretch just before contraction, produced by end-diastolic volume, and it operates through the intrinsic Frank-Starling mechanism. Afterload is the load the ventricle must overcome to eject blood — approximated clinically by aortic (or pulmonary arterial) pressure and by arterial resistance — and it opposes shortening of the myocardial fibers. Contractility (also called inotropy) is the intrinsic strength of contraction at any given preload and afterload, a property controlled chiefly by the autonomic nervous system and circulating catecholamines, and it is the one variable that is not simply a mechanical load but a true change in the heart's contractile state. Distinguishing these three — a distinction Otto Frank's and Ernest Starling's generation had to fight to establish — is the single most important conceptual move in cardiovascular physiology, because each is manipulated by different diseases and different drugs.

Step 1 — Venous return fills the ventricle (preload). During diastole, blood flows from the systemic veins into the right atrium and ventricle (and analogously into the left heart from the pulmonary veins), driven by the pressure gradient between the peripheral veins and the right atrium. The volume present at the end of diastole, the end-diastolic volume (EDV), stretches the sarcomeres of ventricular myocytes. Typical EDV is about 120–130 mL.

Step 2 — The Frank-Starling mechanism converts stretch into force. Within physiological limits, greater sarcomere stretch produces greater force of contraction, entirely independent of nerves or hormones. The classical explanation is length-dependent activation: stretching the sarcomere toward its optimal length (near 2.0–2.2 μm) increases the overlap and cross-bridge cycling efficiency of actin and myosin, and — critically — increases the calcium sensitivity of troponin C, so that the same intracellular calcium transient triggers more cross-bridge formation. This means the heart, over a wide range of filling volumes, ejects a nearly constant fraction of what enters it: the ejection fraction (normally 55–70%) stays roughly stable even as EDV changes, so stroke volume rises automatically when venous return rises.

Step 3 — The ventricle ejects against afterload. Ejection begins once ventricular pressure exceeds aortic (or pulmonary arterial) diastolic pressure, opening the semilunar valve. The pressure the ventricle must generate and sustain throughout ejection — determined mainly by arterial pressure, aortic valve resistance, and by the law of Laplace (wall tension = pressure × radius / wall thickness) — constitutes afterload. Increased afterload (e.g., hypertension, aortic stenosis) means the myocardium must generate more tension before it can shorten at all, which reduces the velocity and extent of fiber shortening for a given contractile state, lowering stroke volume unless compensated.

Step 4 — Contractility shifts the whole force-velocity relationship. Sympathetic nerve terminals release norepinephrine onto β1-adrenergic receptors on ventricular myocytes; circulating epinephrine from the adrenal medulla acts on the same receptors. This activates Gs-protein-coupled adenylyl cyclase, raising intracellular cyclic AMP, activating protein kinase A, which phosphorylates L-type calcium channels (increasing calcium influx during the plateau), phospholamban (relieving its inhibition of the sarcoplasmic reticulum calcium ATPase, SERCA2a, speeding calcium reuptake and relaxation), and troponin I (speeding calcium dissociation from troponin C). The net effect: more calcium enters and is released per beat, cross-bridge cycling is faster and more forceful, and relaxation is faster too — a positive inotropic effect that shifts the entire Frank-Starling curve upward and to the left, so that at any given preload, stroke volume and ejection fraction increase, and end-systolic volume decreases. Parasympathetic (vagal) input has only a minor direct negative inotropic effect on the ventricles (vagal fibers sparsely innervate ventricular muscle compared to the atria and SA/AV nodes).

Step 5 — Heart rate is set independently at the sinoatrial node. As covered in Cardiac Action Potential & Conduction, the SA node's pacemaker potential slope determines intrinsic rate. Vagal acetylcholine acting on M2 muscarinic receptors hyperpolarizes the node and slows the pacemaker current, dominating at rest to hold heart rate near 70 beats/min despite an intrinsic firing rate near 100 beats/min. Sympathetic norepinephrine on β1 receptors accelerates the pacemaker potential, raising rate up to 180–200 beats/min at maximal exertion in young adults.

Step 6 — Output equals return, always. Because the heart cannot pump out more blood than flows in over any sustained interval (it cannot create blood from nothing, and it cannot indefinitely store it without overdistending), sustained cardiac output must equal sustained venous return. This equality is not a coincidence but a direct consequence of the Frank-Starling mechanism: any transient mismatch changes ventricular filling, which changes stroke volume, until the two flows re-equalize. This is the mechanistic bridge to how the circulation as a whole self-regulates, developed further under Blood Pressure & Its Regulation.

Otto Frank (1895), isolated frog ventricle. Working in Munich, the physiologist Otto Frank studied isolated frog heart preparations, systematically varying initial fiber length (by altering diastolic filling) and measuring the pressure the ventricle generated during an isovolumic contraction. He found that within limits, greater initial stretch produced a greater developed pressure — the first quantitative demonstration that the heart's intrinsic mechanical state, not just neural drive, determines its performance. Frank's data were pressure-volume relationships in an isolated, denervated preparation, ruling out any nervous or hormonal explanation for the length-tension effect.

Ernest Starling and colleagues (1912–1914), the heart-lung preparation. At University College London, Starling (with Patterson, Knowlton, and others) built the heart-lung preparation: an anesthetized dog's heart and lungs were isolated from the rest of the systemic circulation, with an artificial reservoir and adjustable resistance substituting for the peripheral vasculature. This let Starling independently vary venous return (by raising or lowering the reservoir, changing filling pressure) and arterial resistance (afterload), while directly measuring stroke volume, cardiac output, and ventricular diastolic volume/pressure. His central finding, published in the 1914 paper with Patterson and Piper: "the energy of contraction is a function of the length of the muscle fiber" — that is, over the physiological range, increasing venous return (and hence diastolic filling) increased stroke work and output, essentially automatically, without any change in heart rate or nervous input, and largely independent of the outflow resistance he simultaneously varied. This became Starling's Law of the Heart, later fused with Frank's earlier work into the eponym "Frank-Starling mechanism." Crucially, Starling showed the denervated, in-situ heart still did this — proving the mechanism is intrinsic to cardiac muscle itself, not reflex-mediated.

Arthur Guyton (1950s–1970s), venous return curves and the systemic circulation. Guyton complemented Frank and Starling's ventricular-function-curve view (cardiac output as a function of atrial/filling pressure) with the "other side" of the story: he plotted venous return itself as a function of right atrial pressure, showing venous return curves have a negative slope (higher right atrial pressure impedes venous return from the periphery) that intersects the heart's positive-sloped Frank-Starling (cardiac function) curve at a single stable operating point. Using dog experiments with right-heart bypass pumps that let him control right atrial pressure independently of the heart's own pumping, Guyton demonstrated that changes in blood volume, venous tone, and total peripheral resistance shift the venous return curve, while changes in contractility and heart rate shift the cardiac function curve — and that cardiac output at steady state is always the point where the two curves cross. This work, summarized in Guyton's textbook graphs still used today, provided the systems-level proof that "cardiac output equals venous return" is not a tautology but an emergent equilibrium, testable and quantifiable.

Sarnoff's ventricular function curves (1950s). Stanley Sarnoff formalized the clinical version of Frank-Starling: plotting stroke work (or stroke volume) against left ventricular end-diastolic pressure across many dog experiments, generating families of curves that shift up with sympathetic stimulation or digitalis (positive inotropes) and down with anesthesia, hypoxia, or heart failure (negative inotropes) — the same family-of-curves logic used clinically today to characterize contractile state at the bedside.

Example 1 — Quantifying compensation in early heart failure. A patient's left ventricle has suffered mild myocardial damage, reducing contractility. At rest their measured values are:

Compare this to a healthy reference (EDV 120 mL, ESV 50 mL, SV 70 mL, EF 58%, HR 70, CO 4.9 L/min). Reasoning through it: cardiac output is nearly preserved (5.28 vs 4.9 L/min) despite clearly reduced contractility — how? First, preload compensation: the failing ventricle dilates (EDV rises from 120 to 160 mL), invoking the Frank-Starling mechanism to partially rescue stroke volume even though the curve itself has shifted downward (ejection fraction has fallen from 58% to 37.5%, the true marker of reduced contractility, since a preload-independent ratio reveals the underlying weakness that raw stroke volume conceals). Second, rate compensation: sympathetic activation (triggered by baroreceptor sensing of reduced effective forward flow) raises heart rate from 70 to 88 beats/min, boosting output further. This is exactly why clinicians use ejection fraction rather than stroke volume alone to diagnose systolic heart failure: reduced EF (here, well below the normal 55–70% range) reveals impaired contractility even when compensatory tachycardia and ventricular dilation have kept raw cardiac output nearly normal — a state termed compensated heart failure. If either compensation fails (e.g., a beta-blocker blunts the tachycardia, or the ventricle dilates beyond the ascending limb of its Starling curve into an over-stretched, poorly responsive plateau), output falls and symptoms of decompensated failure appear.

Example 2 — Distinguishing afterload from contractility in aortic stenosis versus exercise. Consider two scenarios that both increase the pressure the left ventricle must generate. Scenario A: severe aortic stenosis. The aortic valve orifice is narrowed, so the ventricle must generate a much higher systolic pressure (say, 200 mmHg instead of 120 mmHg) to eject blood across the stenotic valve — a pure rise in afterload with no compensatory change in intrinsic contractility. Consequence: for the same contractile state and preload, the velocity and extent of fiber shortening fall, stroke volume drops, end-systolic volume rises, and (over time) the ventricle hypertrophies (increasing wall thickness to normalize wall stress per Laplace's law) but eventually can fail if afterload remains chronically excessive. Scenario B: dynamic exercise. Systolic arterial pressure also rises (say to 160–180 mmHg) during vigorous exercise. Naively this looks like increased afterload too — yet stroke volume increases rather than decreases. Why the opposite outcome? Because exercise simultaneously triggers a large sympathetic surge that dramatically raises contractility (shifting the whole Frank-Starling curve upward and increasing the rate and force of fiber shortening) and increases venous return (skeletal muscle pump, respiratory pump, venoconstriction), raising preload. The positive inotropic and preload effects more than offset the modestly increased afterload, so ejection fraction actually rises during exercise (commonly to 80% or more) rather than falling. This pairing illustrates the essential clinical principle: the same directional change in one variable (afterload) produces opposite outcomes for stroke volume depending on what is simultaneously happening to the other two variables (contractility, preload) — which is exactly why the three determinants must always be assessed together, never in isolation.

Ernest Henry Starling was a physiologist whose career combined meticulous quantitative experimentation with a gift for synthesizing physiological principles into memorable laws — he also co-discovered secretin with William Bayliss (the first recognized hormone) and formulated the Starling forces governing capillary fluid exchange. His 1912–1914 heart-lung preparation experiments, conducted with collaborators including Maurice Patterson and Edward Piper at University College London, required substantial surgical and instrumentation ingenuity: isolating the heart and lungs of an anesthetized dog while keeping them physiologically functional, with an external reservoir substituting for the rest of the circulation so that venous return could be manipulated at will while stroke volume and pressures were recorded on a kymograph. Starling's insistence on quantitative, mechanistic explanation over descriptive anatomy — his famous dictum that physiology's job was to explain the "why" of function in physical and chemical terms — shaped how cardiac output regulation is taught to this day.

In heart failure management, the Frank-Starling framework directly guides therapy: diuretics and venodilators (nitrates) reduce excessive preload in a ventricle stuck on the flat, unresponsive part of a depressed Starling curve; ACE inhibitors, ARBs, and arterial vasodilators reduce afterload to improve forward stroke volume; and inotropes (dobutamine, milrinone) or, longer-term, guideline drugs that improve myocyte calcium handling directly shift the depressed curve back upward. In cardiac surgery and critical care, clinicians titrate intravenous fluids (adjusting preload) and vasopressors or inotropes (adjusting afterload and contractility) while watching cardiac output monitors (thermodilution, pulse-contour analysis, or echocardiographic stroke volume) in real time, essentially performing a bedside version of Guyton's venous-return/cardiac-function curve intersection. In exercise physiology and sports science, cardiac output's five-fold reserve (from roughly 5 L/min at rest to 25+ L/min at maximal exertion in trained athletes) is decomposed into heart rate reserve (up to ~190–200 bpm) and stroke volume reserve (endurance-trained hearts can nearly double stroke volume via enhanced preload use and ventricular compliance), explaining why elite endurance athletes have resting bradycardia (larger stroke volume compensating for a lower rate) and dramatically expanded maximal cardiac output. In pharmacology, beta-blockers, digoxin, and calcium-channel blockers are taught and dosed explicitly in terms of their effects on heart rate, contractility, and afterload — the same three variables introduced here. In veterinary and comparative physiology, the same Frank-Starling logic explains cardiac performance across species from the giraffe (extreme afterload demands from a very long neck) to marine mammals during diving bradycardia. And in critical care shock states, distinguishing cardiogenic shock (primary contractility failure), hypovolemic shock (primary preload failure), and distributive/septic shock (primary afterload/resistance failure) is a direct clinical application of separating the three determinants of stroke volume introduced in this article.

Ask the tutor: How do the venous return curve and cardiac function curve together explain what happens to cardiac output during a hemorrhage?